Concentric Capital Strategies LP Makes New $1.23 Million Investment in Mirion Technologies, Inc. (NYSE:MIR)

Concentric Capital Strategies LP purchased a new position in shares of Mirion Technologies, Inc. (NYSE:MIR) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 111,517 shares of the company’s stock, valued at approximately $1,234,000.

A number of other large investors have also modified their holdings of the business. Innealta Capital LLC purchased a new stake in Mirion Technologies during the 2nd quarter worth approximately $39,000. Quest Partners LLC grew its holdings in shares of Mirion Technologies by 680.5% during the third quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock valued at $74,000 after buying an additional 5,866 shares during the last quarter. Integrated Advisors Network LLC acquired a new position in shares of Mirion Technologies in the 3rd quarter valued at $120,000. Paloma Partners Management Co purchased a new position in Mirion Technologies in the 3rd quarter worth $122,000. Finally, Landscape Capital Management L.L.C. acquired a new stake in Mirion Technologies during the 3rd quarter worth about $147,000. Hedge funds and other institutional investors own 78.51% of the company’s stock.

Analyst Upgrades and Downgrades

MIR has been the topic of a number of research reports. B. Riley assumed coverage on Mirion Technologies in a report on Thursday, September 26th. They issued a “buy” rating and a $14.00 price objective on the stock. The Goldman Sachs Group raised their price target on shares of Mirion Technologies from $13.00 to $16.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Finally, Citigroup upped their price objective on shares of Mirion Technologies from $17.00 to $18.00 and gave the company a “buy” rating in a report on Thursday, October 31st.

Mirion Technologies Stock Down 2.5 %

Shares of MIR stock opened at $16.45 on Tuesday. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. Mirion Technologies, Inc. has a twelve month low of $8.89 and a twelve month high of $17.09. The stock has a 50 day moving average of $14.15 and a 200 day moving average of $11.80.

Mirion Technologies (NYSE:MIR) last posted its earnings results on Tuesday, October 29th. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.02). The firm had revenue of $206.80 million during the quarter, compared to analyst estimates of $203.67 million. Mirion Technologies had a negative net margin of 7.84% and a positive return on equity of 4.33%. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.03 earnings per share. On average, equities research analysts expect that Mirion Technologies, Inc. will post 0.36 EPS for the current fiscal year.

Insider Activity

In other news, CEO Thomas D. Logan sold 7,500 shares of the stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $14.11, for a total transaction of $105,825.00. Following the transaction, the chief executive officer now owns 1,544,017 shares in the company, valued at $21,786,079.87. This trade represents a 0.48 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Emmanuelle Lee sold 3,405 shares of the business’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $14.27, for a total transaction of $48,589.35. The disclosure for this sale can be found here. Insiders have sold 23,405 shares of company stock worth $285,939 in the last ninety days. Company insiders own 2.20% of the company’s stock.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.